Nubain and Migranal drug interactions - a phase IV clinical study of FDA data


There is no or too few drug interactions reported by people who take Nubain and Migranal together.

The phase IV clinical study analyzes what interactions people have when they take Nubain and Migranal. It is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

No or to few reports are found.

What is Nubain?

Nubain has active ingredients of nalbuphine hydrochloride. It is used in pain. Currently, eHealthMe is studying from 1,397 Nubain users.

What is Migranal?

Migranal has active ingredients of dihydroergotamine mesylate. It is used in migraine. Currently, eHealthMe is studying from 543 Migranal users.

Do you take Nubain and Migranal?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

How the study uses the data?

The study uses data from the FDA. It is based on nalbuphine hydrochloride and dihydroergotamine mesylate (the active ingredients of Nubain and Migranal, respectively), and Nubain and Migranal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Nubain and Migranal.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: